SE434745B - 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa - Google Patents

5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa

Info

Publication number
SE434745B
SE434745B SE8003243A SE8003243A SE434745B SE 434745 B SE434745 B SE 434745B SE 8003243 A SE8003243 A SE 8003243A SE 8003243 A SE8003243 A SE 8003243A SE 434745 B SE434745 B SE 434745B
Authority
SE
Sweden
Prior art keywords
dihydro
ylmethyl
amino
benzodioxan
methyl
Prior art date
Application number
SE8003243A
Other languages
English (en)
Swedish (sv)
Other versions
SE8003243L (sv
Inventor
J M Grisar
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE8003243L publication Critical patent/SE8003243L/xx
Publication of SE434745B publication Critical patent/SE434745B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SE8003243A 1979-05-04 1980-04-29 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa SE434745B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,243 US4206125A (en) 1979-05-04 1979-05-04 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives

Publications (2)

Publication Number Publication Date
SE8003243L SE8003243L (sv) 1980-11-05
SE434745B true SE434745B (sv) 1984-08-13

Family

ID=21887496

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003243A SE434745B (sv) 1979-05-04 1980-04-29 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa

Country Status (21)

Country Link
US (1) US4206125A (da)
JP (1) JPS55147274A (da)
AT (1) AT369365B (da)
AU (1) AU531739B2 (da)
BE (1) BE883087A (da)
CA (1) CA1148963A (da)
CH (1) CH645372A5 (da)
DE (1) DE3014738A1 (da)
DK (1) DK154503C (da)
ES (1) ES8104997A1 (da)
FR (1) FR2455598A1 (da)
GB (1) GB2051780B (da)
IE (1) IE49564B1 (da)
IL (1) IL59681A (da)
IT (1) IT1127441B (da)
NL (1) NL8002208A (da)
NO (1) NO153572C (da)
NZ (1) NZ193236A (da)
PH (1) PH15963A (da)
SE (1) SE434745B (da)
ZA (1) ZA801603B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003022A1 (en) * 1986-10-31 1988-05-05 Pfizer Inc. Relatively low molecular weight polypeptides as renin inhibitors
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
US20060205790A1 (en) * 2002-10-22 2006-09-14 Coe Diane M Medicinal arylethanolamine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281245A (da) * 1962-07-20
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative

Also Published As

Publication number Publication date
IL59681A0 (en) 1980-06-30
DK193580A (da) 1980-11-05
IE800572L (en) 1980-11-04
NZ193236A (en) 1982-09-14
ES490814A0 (es) 1981-05-16
BE883087A (fr) 1980-09-01
IT1127441B (it) 1986-05-21
NL8002208A (nl) 1980-11-06
GB2051780B (en) 1982-12-22
DE3014738C2 (da) 1989-08-03
IE49564B1 (en) 1985-10-30
FR2455598B1 (da) 1983-05-27
DK154503B (da) 1988-11-21
US4206125A (en) 1980-06-03
NO153572C (no) 1986-04-16
CA1148963A (en) 1983-06-28
ES8104997A1 (es) 1981-05-16
IT8048373A0 (it) 1980-04-09
PH15963A (en) 1983-05-04
CH645372A5 (de) 1984-09-28
NO153572B (no) 1986-01-06
AT369365B (de) 1982-12-27
DK154503C (da) 1989-04-10
DE3014738A1 (de) 1980-11-13
IL59681A (en) 1984-04-30
ATA232780A (de) 1982-05-15
NO801296L (no) 1980-11-05
AU5707780A (en) 1980-11-06
GB2051780A (en) 1981-01-21
ZA801603B (en) 1981-03-25
SE8003243L (sv) 1980-11-05
JPS642115B2 (da) 1989-01-13
JPS55147274A (en) 1980-11-17
AU531739B2 (en) 1983-09-01
FR2455598A1 (fr) 1980-11-28

Similar Documents

Publication Publication Date Title
EP0074304B1 (fr) Ethers tricycliques, leur préparation et les compositions pharmaceutiques les contenant
KR0181178B1 (ko) 항비만/항과혈당증 성질을 갖는, 치환된 1,3-벤조디옥솔 화합물
FR2569404A1 (fr) Nouveaux derives de 1,2-benzisothiazol-3-ylpiperazine, compositions pharmaceutiques contenant de tels composes et leurs procedes de preparation
EP0243018B1 (en) Thiolactam-n-acetic acid derivatives, their production and use
KR940003071B1 (ko) 벤즈옥사진 유도체 및 이의 제조방법
EP0286515B1 (fr) Nouvelles amines tricycliques dérivées du tétrahydro-5,6,7,8 naphto [2,3b] dihydro-2,3 furanne, et du tétrahydro-6,7,8,9 5H-benzocyclohepta [2,3b] dihydro-2,3 furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
KR100346799B1 (ko) 18환원자를갖는신규한사이클릭뎁시펩타이드및내부기생충을구제하는이의용도
SE434745B (sv) 5-(2-( (2,3-dihydro-1,4-bensodioxan-2-ylmetyl)-amino)-1-hydroxietyl)-2-hydroxibensoesyraderivat och sett att framstella dessa
EP1560818A1 (en) Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
CA1117944A (fr) Procedes de preparation de nouvelles piperazines disubstituees
SE447109B (sv) 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa
LU80720A1 (fr) Polyfluorohydroxyisopropyl carbostyriles bicycliques et tricycliques antihypertensifs,leur preparation et compositions pharmaceutiques les contenant
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
NZ201449A (en) 2-(1,4-benzodioxan-2-ylmethyl)-imidazoline and pharmaceuticals
EP1106608B1 (fr) Nouveaux dérivés (dihydro)benzoxaziniques et (dihydro)benzothiaziniques substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US5268381A (en) Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a high 5-HT1A affinity
SE441447B (sv) 2-hydroxi-5-/1-hydroxi-2-/4-(2-oxo-1-bensimidazolinyl)-piperidino/etyl/bensoesyraderivat och sett att framstella dessa
EP0116372B1 (en) 2h-(1) benzoxepino (5,4-b)-1,4 oxazine derivatives
US4318909A (en) Benzoxazocines
US7781465B2 (en) Therapeutic oxazolidinones and thiazolidinones
US4626522A (en) Benzoxazocines intermediates
FR2473517A1 (fr) Derives d'acide carbothioique de mercaptoacyl amino acides a action anti-hypertensive et leur procede de preparation
JPS61178979A (ja) 3−アミノ−2,3−ジヒドロ−1−ベンゾキセピン化合物、その製造法及び該化合物を含有する、抗抑圧作用を有する医薬調剤
JP2003502318A (ja) シクロ−アミノデプシペプチド類及び内部寄生虫を防除する際のそれらの使用
FR2619816A1 (fr) Derives d'amine et leurs sels, leurs procedes de fabrication, et agent anti-ulcere les contenant

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8003243-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8003243-6

Format of ref document f/p: F